Oncologists’ awareness of the ERAS Protocols and RUSSCO guidelines key provisions on nutritional support in patients with cancer

封面

如何引用文章

全文:

详细

BACKGROUND: Despite existing evidence supporting the effectiveness of nutritional support in oncology care, its practical implementation by oncologists remains insufficient.

AIM: This study aimed to assess practicing oncologists’ awareness of the key provisions of the Russian Society of Clinical Oncology (RUSSCO) guidelines on the diagnosis and treatment of cancer-related malnutrition and to determine their adherence to these recommendations.

METHODS: A survey was conducted among oncologists. The questionnaire included nine statements addressing respondents’ awareness of the provisions of the RUSSCO clinical guidelines on nutritional support and the frequency of its prescription, oncologists’ adherence to Enhanced Recovery After Surgery protocols, as well as their general attitude toward nutritional status screening.

RESULTS: A total of 233 questionnaires were analyzed. The RUSSCO guidelines on nutritional support were known to 179 (76.8%) respondents; nutritional assessment tools were recognized by 54.1% (n = 126), and 43.3% (n = 101) applied them in practice. Sip feeding was recommended by 146 (62.7%) doctors. Nutritional support was provided preoperatively by 43.8% (n = 102), during chemotherapy by 54.5% (n = 126), during radiotherapy by 36.1% (n = 84), and postoperatively by 60.1% (n = 140) respondents. Adherence oncologists to ERAS protocols regarding preoperative fasting and fluid restriction did not exceed 10%. The vast majority (96.6%) of respondents considered nutritional status assessment important.

CONCLUSION: Despite a relatively high level of awareness of clinical recommendations on nutritional support and general acceptance of nutritional status screening, therapeutic nutrition was practically prescribed by only 36.1% to 62.7% of respondents. To shift the paradigm in the prescription of therapeutic nutrition, educational efforts and further studies demonstrating its effectiveness, particularly in the context of ERAS protocols, are required.

作者简介

Alexander Sytov

Blokhin National Medical Research Center of Oncology

Email: drsytov@rambler.ru
ORCID iD: 0000-0002-6426-3200
SPIN 代码: 9859-4667

Cand. Sci. (Medicine)

俄罗斯联邦, 23 Kashirskoe shosse, Moscow, 115522

Olga Obukhova

Blokhin National Medical Research Center of Oncology

编辑信件的主要联系方式.
Email: obukhova0404@yandex.ru
ORCID iD: 0000-0003-0197-7721
SPIN 代码: 6876-7701

Cand. Sci. (Medicine)

俄罗斯联邦, 23 Kashirskoe shosse, Moscow, 115522

Svetlana Matveeva

Blokhin National Medical Research Center of Oncology

Email: matweeva.sveta@yandex.ru
ORCID iD: 0009-0009-0154-5233
俄罗斯联邦, 23 Kashirskoe shosse, Moscow, 115522

Evgeny Budargin

Blokhin National Medical Research Center of Oncology

Email: budarginy@gmail.com
ORCID iD: 0009-0003-2359-6871
俄罗斯联邦, 23 Kashirskoe shosse, Moscow, 115522

Filipp Kudryavtsev

Blokhin National Medical Research Center of Oncology

Email: fil2672@rambler.ru
ORCID iD: 0000-0002-1828-9768
SPIN 代码: 5828-5615
俄罗斯联邦, 23 Kashirskoe shosse, Moscow, 115522

参考

  1. Muscaritoli M, Arends J, Bachmann P, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr. 2021;40(5):2898–2913. doi: 10.1016/j.clnu.2021.02.005 EDN: PYNEVI
  2. Arends J, Strasser F, Gonella S, et al. Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines. ESMO Open. 2021;6(3):100092. doi: 10.1016/j.esmoop.2021.100092 EDN: JUJSZN
  3. Ivanova AS, Obukhova OA, Kurmukov IA, Wolf LYa. Review of ESPEN-2021 practical recommendations for cancer patients. Part 1. Clinical nutrition and metabolism. 2022;3(3):140–152. doi: 10.17816/clinutr111900 EDN: YLUOMT
  4. Ivanova AS, Obukhova OA, Kurmukov IA, Wolf LYa. Review of ESPEN-2021 practical recommendations for cancer patients. Part 2: specific issues of nutritional support. Clinical nutrition and metabolism. 2022;3(4):193–206. doi: 10.17816/clinutr119059 EDN: TKPXSS
  5. Sytov AV, Zuzov SA, Kukosh MY, et al. Nutritional support. RUSSCO practical recommendations, part 2. Malignant tumors. 2024;14(3s2):163–173. doi: 10.18027/2224-5057-2024-14-3s2-2-08
  6. Obukhova OA, Bagrova SG, Besova NS, et al. Assessment of the nutritional status of patients with inoperable gastric cancer at the time of initiation of antitumor treatment. Preliminary results of a prospective observational study. Difficult patient. 2018;16(6):6–11. EDN: UYUQCM
  7. Obukhova OA, Snegovoy AV, Kurmukov IA, et al. Nutritional status of cancer patients before antitumor treatment: a single-center prospective observational study. Clinical nutrition and metabolism. 2020;1(4):178–189. doi: 10.17816/clinutr64707 EDN: NIOWHL
  8. Obukhova OA, Kurmukov IA, Semenova AA, et al. Nutritional deficiency in patients with newly diagnosed diffuse large B-cell lymphoma. Prevalence and approaches to correction. Oncohematology. 2024;19(3):233–242. doi: 10.17650/1818-8346-2024-19-3-233-242 EDN: RUTLZP
  9. Practical recommendations for the prevention and treatment of complications of malignant tumors and antitumor drug therapy. Rosoncoweb. Russian Society of Clinical Oncology [Internet]. Available from: https://rosoncoweb.ru/standarts/suptherapy/
  10. Bausys A, Luksta M, Anglickiene G, et al. Effect of home-based prehabilitation on postoperative complications after surgery for gastric cancer: randomized clinical trial. Br J Surg. 2023;110(12):1800–1807. doi: 10.1093/bjs/znad312 EDN: FWHLGY
  11. Tsiryatyeva SB, Satyvaldaev MN, Abgaryan AS, Pylenko SA. Clinical and pharmacoeconomic effectiveness of preoperative nutritional support in early rehabilitation of patients with lung cancer. Medical Science and Education of the Urals. 2019;20(3(99)):154–157. EDN: PCORFA
  12. Ruggeri E, Giannantonio M, Agostini F, et al. Home artificial nutrition in palliative care cancer patients: impact on survival and performance status. Clin Nutr. 2020;39(11):3346-3353. doi: 10.1016/j.clnu.2020.02.021
  13. Kotov SV, Khachatryan AL, Guspanov RI, et al. Comparative analysis of the use of the accelerated recovery protocol (ERAS) in radical cystectomy. Experimental and Clinical Urology. 2020;(2):78–83. doi: 10.29188/2222-8543-2020-12-2-78-83 EDN: FIHUNZ
  14. Dalgatov KD, Kozodaeva MV, Titkova SM, et al. Evaluation of the safety of the accelerated recovery protocol (ERAS) in the treatment of patients after pancreaticoduodenal resection. Surgery. Journal im. N.I. Pirogov. 2021;11:19–26. doi: 10.17116/hirurgia202111119 EDN: RHWFIP
  15. Kurtser MA, Dubinin AA, Grodnitskaya EE, et al. Use of the ERAS protocol in elective gynecological surgery: a prospective non-randomized controlled study. Farmateka. 2019;26(6):36–41. doi: 10.18565/pharmateca.2019.6.36–41
  16. Kabanova A.S. Study of the prevalence of the use of ERAS protocol components in colorectal surgeries. In: MNSK-2020. Medicine. Proceedings of the 58th International Scientific Student Conference. 2020. P. 34. EDN: IGIJLQ
  17. Weimann A, Braga M, Carli F, et al. ESPEN practical guideline: Clinical nutrition in surgery. Clin Nutr. 2021;40(7):4745–4761. doi: 10.1016/j.clnu.2021.03.031

补充文件

附件文件
动作
1. JATS XML

版权所有 © Eco-Vector, 2024

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).